Education
About Us
Working with TipRanks
Follow Us
Anton Schrofner Insider Profile
4 Followers
Anton Schrofner, Chief Medical Officer at Draegerwerk AG & Co. KGaA, holds ― shares in Draegerwerk AG & Co. KGaA (Ticker: GB:0K5E). Most recently, Anton Schrofner Sold 600 shares of Draegerwerk AG & Co. KGaA on Jan 22, 2026 for an estimated value of €51.59K.
Anton Schrofner has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Anton Schrofner does not currently own shares as a corporate insider.
A breakdown of Anton Schrofner's holdings
Insider Roles
Chief Medical Officer
Roles that Anton Schrofner holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Anton Schrofner
Anton Schrofner's Trading History
List of latest transactions for each holding click on a transaction to see Anton Schrofner's performance on stock
You May Also Like
Anton Schrofner insider profile FAQ
What is the percentage of profitable transactions made by Anton Schrofner?
The percentage of profitable transactions made by Anton Schrofner is ―.
What is the average return per transaction made by Anton Schrofner?
The average return per transaction made by Anton Schrofner is ―.
What stocks does Anton Schrofner hold?
Anton Schrofner holds: GB:0K5E stocks.
What was Anton Schrofner’s latest transaction?
Anton Schrofner latest transaction was an Informative Sell of €51.59K.
What was Anton Schrofner's most profitable transaction?
Anton Schrofner’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Anton Schrofner's role in Draegerwerk AG & Co. KGaA?
Anton Schrofner's role in Draegerwerk AG & Co. KGaA is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.